Tumour vaccines: Personal training by vaccination

Nature Reviews Cancer 17, 451 (2017). doi:10.1038/nrc.2017.61 Author: Ulrike Harjes Two groups have shown that personalized, neoantigen-based tumour vaccines elicit effective T cell responses in patients with advanced melanoma, leading to favourable clinical outcomes. Combination with checkpoint blockade can be of additional benefit.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research